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Abstract The freshwater ciliate Tetrahymena pyriformis is an
ubiquitous organism that is present in all aquatic ecosystems.
This protozoan showed a clear resistance against some polycyclic
aromatic hydrocarbons which can be attributed to an efflux pump
probably of the multidrug resistance (MDR) type. Immunocy-
tochemical detection showed a positive stain of ciliate cells using
the monoclonal antibodies 4E3, raised against P-glycoprotein
(P-gp). The kinetics of P-gp expression were studied for control
cultures and cultures treated with 15 WM benzo(a)pyrene.
Western blot analysis using the Ab1, anti-P-gp polyclonal
antibodies indicates the presence of two bands of 66 and
96 kDa of which the intensity increased with time in
benzo(a)pyrene-treated ciliates. Uptake experiments with target
compounds for the MDR pump, namely adriamycin, rhodamine
123 and two polycyclic aromatic hydrocarbons, benzo(a)pyrene
and 7,12-dimethylbenzanthracene, were carried out by flow
cytometry, in the presence or absence of cyclosporin (an inhibitor
of the multidrug resistant pump). The data indicate that the
accumulation of these compounds by ciliate cells is significantly
enhanced in the presence of cyclosporin. This suggests that
Tetrahymena is provided with a P-gp-like system that is
functionally active in a way similar to that of the mammalian
P-gp.
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1. Introduction
Protozoan ciliates are unicellular eukaryotic organisms that
are present in all aquatic ecosystems. The freshwater ciliate
Tetrahymena pyriformis is an organism of choice in cytotox-
icity studies [18]. Its short generation time and the fact that it
can be grown in axenical culture are especially advantageous
for studying the action of xenobiotics on several generations
of cells. This ciliate has been used to determine the e¡ects of
di¡erent xenobiotics including insecticides [9], herbicides [21],
mycotoxins [5] or drugs such as antibiotics [1].
In spite of its general sensitivity to toxic agents, T. pyrifor-
mis does not show any signi¢cant sign of cytotoxicity in the
presence of polycyclic aromatic hydrocarbons (PAHs) such as
benzo(a)pyrene (BP), 3-methylcholanthrene (3MC), benzan-
thracene (BA) and 7,12-dimethylbenzanthracene (DMBA)
[2]. The latter are highly toxic ubiquitous environmental con-
taminants and have been used as representative compounds to
investigate the mode of action of PAHs, in particular cyto-
chrome P450 induction [4]. The PAH uptake, studied in T.
pyriformis by £ow cytometry (FCM) in our laboratory, shows
immediate accumulation followed by rapid elimination of
these products by the cells. Results of gas chromatography-
mass spectrometry analysis indicate that PAH elimination is
not linked to biotransformation but to rapid e¥ux of these
molecules by the cells [2].
Multidrug resistance (MDR) refers to patterns of resistance
that develop in tumor cells against a wide range of natural
product-derived anti-cancer agents. P-glycoprotein (P-gp), a
transmembrane e¥ux pump encoded by the MDR gene
(MDR1), transports various lipophilic drugs out of cells that
initially enter the cells by passive di¡usion [19]. BP and 3MC
are known as substrates for the MDR e¥ux pump in a hep-
atocyte culture [7]. The presence of the MDR e¥ux pump or
MDR e¥ux pump-like has already been demonstrated in
freshwater and marine organisms such as mussels and sponges
[14], in the parasitic protozoans Leishmania donovani [11]
and Plasmodium falciparum [13] and even in bacterial cells
[10].
The activity of the MDR pump can be modulated by mol-
ecules such as verapamil and cyclosporin which act as com-
petitive inhibitors [17,20]. Data obtained in our laboratory on
BP uptake in T. pyriformis show that, in the presence of
verapamil, BP is accumulated in larger amounts in cells.
With cyclosporin, the accumulation of this PAH is several
times greater than under control conditions [2]. These results
suggest that the resistance of T. pyriformis against PAH cyto-
toxicity may be attributed to the rapid e¥ux of these com-
pounds from the cells via an e¥ux pump probably of the
MDR type.
The purpose of this study was to provide further evidence
for the existence of a P-gp-like system in T. pyriformis. In this
work, immunocytochemical detection shows a positive stain
of ciliate cells and Western blot analysis indicates the presence
of two polypeptides. Uptake experiments with two target
compounds for the MDR pump, adriamycin (ADR) and
rhodamine 123 (Rhod), and two PAHs, BP and DMBA, in-
dicate that these compounds are clearly more accumulated by
ciliate cells in the presence of cyclosporin, a well-known in-
hibitor of the MDR pump. Overall, these results strongly
suggest that T. pyriformis is provided with a P-gp-like system
that is functionally active in a way similar to the mammalian
P-gp.
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2. Materials and methods
2.1. Materials
BP and DMBA were purchased from Aldrich Chemical (Milwau-
kee, WI, USA). Proteose peptone and yeast extract were purchased
from Difco Laboratories (Detroit, MI, USA). Cyclosporin was pur-
chased from Sandoz Canada (Veterinary Teaching Hospital of Ontar-
io, Veterinary College, Guelph, Ont., Canada). 4E3 monoclonal anti-
bodies were purchased from Signet Laboratories (Dedham, MA,
USA). Ab1 anti-P-gp mouse polyclonal antibodies were purchased
from CIE Oncongene science (Horby, Ont., Canada). Anti-rat
F(abP) monoclonal antibodies were purchased from Cedar Lane
(Ont., Canada). Rhod, ADR, anti-mouse IgG monoclonal antibodies
and other chemicals were purchased from Sigma Chemical (St. Louis,
MO, USA).
2.2. T. pyriformis culture
T. pyriformis GL, a micronucleate strain in the exponential growth
phase, was used. Ciliate culturing was carried out axenically at 28‡C
in PPYS medium (7.5 g/l proteose peptone, 7.5 g/l yeast extract, salt
solution) [1].
2.3. Xenobiotic exposure
BP and DMBA were dissolved in dimethyl formamide (DMF).
ADR and Rhod were dissolved in dimethylsulfoxide (DMSO). The
¢nal concentrations of DMF and DMSO in the culture were 0.2 and
0.5%, respectively. The cells were exposed to concentrations of 1 WM
BP, DMBA and Rhod and 30 WM ADR.
2.4. Uptake of xenobiotics by FCM
BP, DMBA, Rhod and ADR are £uorescent molecules. Their up-
take by T. pyriformis was measured by FCM using a FACS Vantage
£ow cytometer (Becton Dickinson) according to the technique de-
scribed by Bamdad et al. [2]. PAHs were excited at 351^364 nm
with an Enterprise ion argon laser (COHERENT), which had an out-
put power of 50 mW. The £uorescence intensities were obtained using
a 405 þ 10 nm bandpass ¢lter. The emission wavelengths for ADR and
Rhod were 660 and 514 nm, respectively. For each cytometric param-
eter investigated (Rhod, ADR and PAH £uorescence), 10 000 events
(cells) were analyzed per condition and £uorescence measurements
were on the logarithmic scale. The mean £uorescence for any given
population was provided by Lysis II instrument software and ex-
pressed in £uorescence units (FU). Each experiment was performed
at least three times.
2.5. Immunocytochemistry
15 ml of ciliate culture in the exponential growth phase (about
20 000 cells/ml) was concentrated (centrifugation at 3000Ug for
5 min). The pellet was ¢xed for 5 min in 4% paraformaldehyde in
phosphate-bu¡ered saline (PBS) pH = 7.2, at room temperature. After
three washes in PBS, the cells were laid on slides. Next, after washing
in PBS, the cells were incubated for 60 min in a blocking solution
(PBS pH = 7.4, 11.5 mM NaH2PO4, 99.2 mM NaCl, 2.1 mM MgCl2,
1.05 g/l casein, 30 g/l bovine serum albumin, 100 ml fetal bovine
serum). After three washes in 0.07% Tween-PBS, the cells were incu-
bated for 1 h at room temperature in humidi¢ed boxes with the mouse
monoclonal antibodies 4E3 or with control isotype IgG2a anti-rat
antibody at 5 Wg/ml. After washing three times in 0.07% Tween-
PBS, the slides were incubated for 1 h at room temperature in anti-
mouse IgG alkaline phosphatase-conjugated goat anti-mouse second-
ary antibody diluted 1:250. The slides were then washed three times in
0.07% Tween-PBS and the positive reaction was developed by placing
the samples for 45 min in a solution composed of 200 Wg/ml 5-bromo-
4-chloro-3-indolyl phosphate, 200 Wg/ml nitro blue tetrazolium,
100 mM NaCl, 5 mM MgCl2 in 100 mM Tris bu¡er pH = 9.5.
2.6. Western blot analysis
Control cells and cells treated with 15 WM BP for 10, 60 or 120 min
were centrifuged (3000 rpm, 10 min at 4‡C) and the pellet was recov-
ered in 4 ml of bu¡er solution (0.8 M sucrose, 5 mM Tris-HCl, 5 mM
MgCl2, pH = 7.2). After centrifugation (3000 rpm, 5 min at 4‡C), the
supernatant was removed and the pellet was treated with 300 Wl of 0.4
M sucrose bu¡er, pH = 7.2, and protease inhibitors (1 mM phenyl-
methylsulfonyl £uoride, 5 WM leupeptin, 1 mM EGTA, 1 mM
EDTA). The cells were then homogenized with a potter tissue homog-
enizer at 4‡C. Cell extracts were sonicated (2U10 s at 4‡C) and diluted
1:4 in sample bu¡er composed of 47.5% (v/v) deionized water, 12.5%
0.5 mM Tris-HCl pH 6.8, 10% glycerol, 20% SDS (10% w/v), 5% L-
mercaptoethanol and 5% bromophenol blue (1% w/v) to a ¢nal pro-
tein concentration of 0.5 mg/ml. The samples were sonicated (4U10 s
at 4‡C) and used for immunodetection of P-gp by Western blot anal-
ysis according to the technique described by Beaulieu et al. [3] and
using the anti-P-gp polyclonal antibodies Ab1 (diluted 1:2000).
3. Results
3.1. Immunodetection of P-gp in Tetrahymena
Immunodetection of P-gp was ¢rst carried out in T. pyri-
formis by immunocytochemistry. Immunocytochemical detec-
tion of P-gp was performed on cells ¢xed with 4% parafor-
Fig. 1. Immunocytochemical detection of P-gp in T. pyriformis GL.
(A) The ciliate cells were ¢xed with 4% paraformaldehyde and then
stained with the mouse monoclonal anti-P-gp antibodies 4E3 at
5 Wg/ml. The immunocomplexes were incubated for 1 h at room
temperature in anti-mouse IgG alkaline phosphatase-conjugated
goat anti-mouse secondary antibody diluted 1:250. (B) Control
anti-mouse IgG alkaline phosphatase-conjugated goat anti-mouse
secondary antibody diluted 1:250. Magni¢cation, U40.
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maldehyde, using the mouse monoclonal antibodies anti-P-gp
4E3. In parallel, controls for isotype IgG2a and for secondary
antibodies were performed using the anti-rat F(abP) monoclo-
nal antibodies and the anti-mouse IgG alkaline phosphatase-
conjugated antibodies, respectively. The results showed a pos-
itive stain with the anti-P-gp 4E3 (Fig. 1A), in contrast to
what was seen in the controls (Fig. 1B).
Immunodetection of P-gp was then carried out by Western
blot analysis on a T. pyriformis control culture and cultures
treated with 15 WM BP for 10, 60 and 120 min. The polyclonal
anti-P-gp Ab1 was used for this detection. The results are
presented in Fig. 2. They show the presence of two proteins
with apparent molecular masses of 66 and 96 kDa, detected
both in controls (a) and treated ciliates (b^d). The stain in-
tensity of these two bands seems to be less pronounced in the
control cultures (a) and in the cells treated with BP for 10 min
(b) than in samples exposed to BP for 60 (c) and 120 min (d).
3.2. Uptake of Rhod, ADR, DMBA and BP by T. pyriformis
In this series of experiments, the uptake of Rhod and ADR,
two well-known target molecules for P-gp, and the uptake of
the two PAHs BP and DMBA was studied in T. pyriformis.
The kinetics of Rhod uptake were studied under di¡erent
conditions over a 3 h period in ciliate culture (Fig. 3). The
uptake of 1 WM Rhod led to a rapid increase in intracellular
£uorescence (40.5 FU at 30 min) that decreased slightly after-
wards (27.8 FU at 120 min). Rhod uptake (1 WM) studied in
the presence of 1 WM BP (added in ciliate culture at the same
time) showed a greater accumulation of Rhod in cells with
52.4 FU at 30 min. Addition of 5 WM cyclosporin (an inhib-
itor of the P-gp pump) 5 min before addition of Rhod led to a
much more rapid Rhod accumulation in the cells (130.6 FU at
15 min). This rate then decreased (56.9 FU) at 120 min and
remained stable. In parallel, addition of 5 WM cyclosporin to
ciliate cultures 30 min after treatment with Rhod (1 WM)
again produced a clear accumulation of Rhod in the cells
(82.9 FU at 60 min). Finally, Rhod uptake studied in a ciliate
culture treated with 1 WM Rhod for 40 min (43.6 FU at 30
min) and then transferred to culture medium without Rhod
showed a rapid and clear decrease in Rhod from the cells (9.9,
5.2 and 4.7 FU at 60, 120 and 180 min, respectively).
With 30 WM ADR (Table 1), intracellular £uorescence in-
creased rapidly over the ¢rst 60 min (17.6 FU) and then re-
mained relatively stable (17.4 FU at 180 min). In the presence
of 5 WM cyclosporin added to the culture 5 min before ADR,
ADR accumulation increased clearly and rapidly with a max-
imum of 46.1 FU at 60 min.
Fig. 2. Western blot analysis of P-gp in T. pyriformis GL. The cili-
ate cultures were treated with 15 WM BP for 10, 60 and 120 min
and then processed as described in Section 2. The polyclonal anti-P-
gp antibodies Ab1 were used for this detection. (a) Control culture,
(b) cultures treated with BP for 10 min, (c) 60 min, (d) 120 min, (e)
kidney brush border membranes used as positive control.
Fig. 3. FCM analysis of Rhod-induced £uorescence in the presence
of cyclosporin in T. pyriformis GL cultures. Time course of mean
cellular £uorescence of control cells and of cells exposed to 1 WM
Rhod and 5 WM cyclosporin (cyclo). Data from one experiment are
representative of three similar experiments. ^a^, 0.5% DMSO con-
trol ; ^O^, 5 WM cyclo; ^F^, 1 WM Rhod; ^7^, 1 WM BP; ^U^,
1 WM Rhod and 1 WM BP added at the same time; ^b^, 1 WM
Rhod during 30 min and then 5 WM cyclo added; ^R^, 5 WM cyclo
during 5 min and then 1 WM Rhod added; ^U^, 1 WM Rhod dur-
ing 40 min and cells were transferred in free Rhod medium.
Table 1
FCM analysis of ADR, DMBA and BP-induced £uorescence in the presence of cyclosporin in T. pyriformis
Time, min Controls ADR DMBA BP
0.5% DMSO 0.2% DMF 5 WM cyclo 30 WM ADR ADR/cyclo 1 WM DMBA DMBA/cyclo 1 WM BP BP/cyclo at 60 min
0 5 2.7 6 4.3 4.3 4.3 4.3 2.7 2
30 5.6 2.6 6.4 14.7 39.3 39.3 54. 259.4 210.3
60 5 3.3 6.4 17.6 46.1 19.6 329.3 126 125
120 4.4 2.7 7.5 14.3 35.2 9.9 552.5 90.7 1409.4
180 5 2.6 7.2 17.4 35.1 14 280.4 76.9 831
Time course of mean cellular £uorescence of controls cells : 0.5% DMSO, 0.2% DMF and 5 mM cyclosporin (cyclo). Cells exposed to 30 WM
ADR, 1 WM DMBA or 1 WM BP. Cells exposed at the same time to 5 WM cyclosporin and 30 WM ADR (ADR/cyclo) or 5 WM cyclosporin
and 1 WM DMBA (DMBA/cyclo). Cells exposed to 1 WM BP and to 5 WM cyclosporin after 60 min of treatment to BP (BP/cyclo at 60 min).
Data from one experiment are representatives of three similar experiments.
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The results on DMBA accumulation (Table 1) showed an
increase in intracellular £uorescence with 1 WM of this PAH,
with a maximum of 39.33 FU at 30 min. This rate decreased
and reached the control values at 120 min (9.9 FU). In the
presence of 5 WM cyclosporin added 5 min before DMBA, the
PAH was accumulated very rapidly in ciliate cells with a max-
imum of 552.5 FU at 120 min. This rate decreased to 280.4
FU at 180 min.
BP uptake followed in ciliate culture (Table 1) showed that
this PAH at 1 WM was accumulated rapidly by the cells (259.4
FU at 30 min) but its cellular level decreased progressively
thereafter (76.9 FU at 180 min). Moreover, addition of 5 WM
cyclosporin, 60 min after BP addition, caused an extensive
increase in BP £uorescence in cells with 125.8 FU at 60 min
(before cyclosporin addition) and 1409 FU at 120 min (after
cyclosporin addition).
4. Discussion
Many aquatic organisms thrive and reproduce in polluted
waters. This fact indicates that they are well-equipped with
defense systems against many toxic xenobiotics simultane-
ously present in the environment. According to Kurelec [14],
the biochemical mechanism underlying such ‘multixenobiotic’
resistance in freshwater and marine mussels, in several marine
sponges and in freshwater ¢sh is similar to the mechanism of
MDR found in tumor cells that have become refractory to
treatment, a phenomenon that occurs with a variety of che-
motherapeutic agents. P-gp, a transmembrane e¥ux pump for
anti-tumor drugs, transports lipophilic molecules out of cells
that initially enter the cells by passive di¡usion [19].
The freshwater ciliate T. pyriformis is a ubiquitous unicel-
lular eukaryotic organism that shows resistance against PAH
toxicity (BP, 3MC, BA and DMBA). Previous studies carried
out in our laboratory showed that this resistance is linked to a
rapid e¥ux of these compounds by the cells. The e¥ux mech-
anism could be attributed to the presence of an e¥ux pump of
the P-gp type since in the presence of P-gp inhibitors, PAH
accumulation was enhanced [2]. The present study provides
further evidence supporting the existence of a P-gp-like system
in Tetrahymena.
Immunodetection methods were applied to con¢rm the
presence of a P-gp-like system in T. pyriformis. The results
of immunocytochemistry showed clear positive staining of the
cells. The mouth organelles are labelled in accordance with
their high ciliary density. The labelling of the cell body pe-
riphery may be related to the presence of two membrane
systems: the plasma membrane, in continuity with the ciliary
membrane system, and that of underlying alveolar sacs. West-
ern blot analysis revealed two immunoreactive bands corre-
sponding to proteins of 66 and 96 kDa. Moreover, exposure
of the cells to BP led to enhanced expression of the proteins,
as judged from the increase in the intensity of the bands in
samples from cultures incubated with this compound for 60
and 120 min. It is worth noting that the time course of cellular
accumulation of BP, as studied by FCM in T. pyriformis [2], is
correlated with the P-gp expression results. Indeed, BP accum-
ulated rapidly in ciliate cells within about 20 min, it was
then eliminated e⁄ciently by the cells and after 60 min of
exposure, the amount of BP in the cells had stabilized at
very low levels.
Usually, the MDR (in human) or mdr (in non-human spe-
cies) phenotype in mammalian cells involves increased expres-
sion of an approximately 170 kDa plasma membrane P-gp
[19]. The blood brain barrier also expresses a P-gp with a
molecular weight of 190 kDa [3]. In a marine sponge, a 150
kDa drug-binding glycoprotein was described [14] and in oth-
er sponge species and in mussels, a 170 kDa protein was
found [14]. In P388 murine leukemia cells, a mini P-gp with
a molecular weight of approximately 65 kDa was identi¢ed
[12]. In prokaryotic cells, a striking homology was detected
between P-gp and the HlyB protein, a 66 kDa Escherichia coli
membrane protein required for export of hemolysin. P-gp can
be seen as a tandem duplication of the HlyB protein [10]. The
presence of immunoreactive proteins observed by Western
blotting suggests that T. pyriformis expresses two polypeptides
(66 and 96 kDa) that share epitopes with the mammalian P-gp
but that are smaller than the latter.
In order to support the evidence obtained from immunode-
tection, the presence of a P-gp-like system acting as a multi-
drug transporter in T. pyriformis was veri¢ed through uptake
studies. The transport of molecules that are well-known tar-
gets for the P-gp pump, namely Rhod and ADR, was meas-
ured by FCM. This methodology allows for the accumulation
of £uorescent substrates by cells to be followed on a real time
basis. FCM has been widely used for studying MDR [15]. It is
a novel approach for examining the response of unicellular
organisms such as Tetrahymena when they are exposed to
environmental contaminants [2]. Rhod is a model molecule,
frequently used along with FCM for P-gp e¥ux studies [8,16].
Rhod intracellular levels were clearly more important in the
presence of cyclosporin, whether the inhibitor was added prior
to Rhod or later during the course of the experiment, provid-
ing additional support for the existence of a P-gp-like mech-
anism. Moreover, under conditions where Rhod and BP were
added in a cell culture at the same time, Rhod accumulation
was greater. Since BP is a known target for P-gp, it can there-
fore compete with Rhod for the e¥ux pump. This may ex-
plain the larger accumulation of Rhod under these conditions.
The cytotoxic drug ADR, an antracyclin highly associated
with resistance mechanisms, has the advantage of being £uo-
rescent [6,15]. The uptake of ADR followed in T. pyriformis
showed a rapid cellular accumulation of this product reaching
levels that remained stable. In the presence of cyclosporin, a
classical inhibitor of P-gp, ADR accumulation was clearly
enhanced. Finally, the DMBA and BP transport study in T.
pyriformis showed a rapid uptake and e¥ux of these mole-
cules by the cells. However, adding cyclosporin at the begin-
ning or during the course of the experiment clearly increased
the rate of DMBA or BP accumulation, again suggesting a
role for a P-gp-like system.
The uptake experiments that we carried out in T. pyriformis
using di¡erent compounds always demonstrated a rapid in£ux
of these molecules into cells, while e¥ux pro¢les varied ac-
cording to each molecule. With ADR and Rhod, after the
initial phase of accumulation, there was a stabilization of
the cellular £uorescence, indicating that the rate of in£ux
and that of e¥ux were in equilibrium. In the case of PAHs,
a clear and rapid e¥ux of the compounds was detected with
the ciliate. The PAH e¥ux remained e¡ective over time, al-
lowing the cells to eliminate most of the toxic compound [2].
The fact that T. pyriformis is a ubiquitous organism in fresh-
water and the fact that PAHs are a major source of pollution
in aquatic ecosystems may explain the particular action of a
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P-gp-like system against PAHs in Tetrahymena. This ciliate
probably developed a new way of detoxication by this cell
membrane resistance mechanism. The molecular characteriza-
tion of an MDR type system in Tetrahymena deserves further
investigation.
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